The pacemaker market is estimated to achieve USD 5.1 billion by 2024 from USD 4.3 billion in 2017, at a CAGR of 2.1%. Pacemakers are medical devices that regulate the rate at which the heart’s chambers pump blood and are meant for persons who suffer irregular heartbeats. This can be caused by several variables, including environmental, genetic, and behavioural factors, or a combination of them.
Pacemakers are linked to longer lifespans and life expectancies in persons who have them implanted. On the other hand, electronic pacemakers are related to several issues, including their size. Even though current units can be as little as a grain of rice, some users find them difficult to wear. Pacemakers, as well as the wires that connect them to their power supplies, are implanted in the chest. This configuration increases the risk of pacemaker issues, including an infection or irritation around the wires, sometimes known as ‘leads’ and sudden battery failures. There are also cases of pacemaker lead corrosion and product recalls, both of which have resulted in impromptu pacemaker removal procedures for patients with who any of these potentially deadly situations has afflicted.
